← Back to Analyst Consensus 
BCYC Buy
BICYCLE THERAPEUTICS PLC
Current Price —
Implied Upside —
Analysts 16
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Oct 28, 2026 (2 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jul 30, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Apr 8, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Mar 18, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Mar 18, 2026 | RBC Capital | maintain | Sector Perform → Sector Perform | — | 55% |
| Mar 18, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 46% |
| Mar 18, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Nov 24, 2025 | Truist Securities | initiate | — → Hold | $10 | 54% |
| Oct 31, 2025 | Citizens | maintain | Market Outperform → Market Outperform | $12 | 46% |
| Oct 31, 2025 | RBC Capital | downgrade | Outperform → Sector Perform | $11 | 55% |
| Aug 12, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $10 | 53% |
| Aug 12, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $13 | 54% |
| Aug 11, 2025 | Oppenheimer | maintain | Outperform → Outperform | $44 | 52% |
| Jul 17, 2025 | RBC Capital | maintain | Outperform → Outperform | $25 | 55% |
| May 6, 2025 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $17 | 54% |
| May 2, 2025 | RBC Capital | maintain | Outperform → Outperform | $32 | 55% |
| May 2, 2025 | B. Riley Securities | maintain | Neutral → Neutral | $14 | 54% |
| May 2, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $22 | 53% |
| May 2, 2025 | Needham | reiterate | Buy → Buy | $29 | 50% |
| May 1, 2025 | Barclays | maintain | Overweight → Overweight | $15 | 53% |
| Apr 29, 2025 | Needham | maintain | Buy → Buy | $29 | 50% |
| Apr 9, 2025 | Needham | reiterate | Buy → Buy | $30 | 50% |
| Mar 11, 2025 | Needham | reiterate | Buy → Buy | $30 | 50% |
| Feb 26, 2025 | Citizens Capital Markets | reiterate | Market Outperform → Market Outperform | $26 | 49% |
| Feb 26, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $33 | 44% |
| Feb 26, 2025 | Needham | reiterate | Buy → Buy | $30 | 50% |
| Jan 22, 2025 | Stephens & Co. | reiterate | Equal-Weight → Equal-Weight | $15 | 54% |
| Jan 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $33 | 44% |
| Jan 13, 2025 | Needham | reiterate | Buy → Buy | $32 | 50% |
| Dec 18, 2024 | JMP Securities | maintain | Market Outperform → Market Outperform | $26 | 53% |
| Dec 16, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $33 | 44% |
| Dec 13, 2024 | B. Riley Securities | maintain | Neutral → Neutral | $17 | 54% |
| Nov 8, 2024 | Stephens & Co. | initiate | — → Equal-Weight | $25 | 54% |
| Nov 1, 2024 | RBC Capital | reiterate | Outperform → Outperform | $35 | 55% |
| Nov 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $55 | 44% |
| Oct 31, 2024 | Needham | reiterate | Buy → Buy | $38 | 50% |
| Oct 24, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $55 | 44% |
| Oct 24, 2024 | Needham | reiterate | Buy → Buy | $38 | 50% |
| Sep 16, 2024 | JMP Securities | reiterate | Market Outperform → Market Outperform | $32 | 53% |
| Sep 16, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $55 | 44% |
| Sep 16, 2024 | Needham | reiterate | Buy → Buy | $38 | 50% |
| Sep 9, 2024 | Needham | reiterate | Buy → Buy | $38 | 50% |
| Sep 9, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Sep 6, 2024 | RBC Capital | initiate | — → Outperform | $35 | 55% |
| Aug 7, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $55 | 44% |
| Aug 7, 2024 | Oppenheimer | maintain | Outperform → Outperform | $48 | 52% |
| Aug 7, 2024 | Needham | reiterate | Buy → Buy | $38 | 50% |
| Aug 7, 2024 | B. Riley Securities | downgrade | Buy → Neutral | $28 | 54% |
| May 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $55 | 44% |
| Apr 10, 2024 | Needham | reiterate | Buy → Buy | $43 | 50% |
| Feb 21, 2024 | Canaccord Genuity | reiterate | Buy → Buy | $60 | 48% |
Price Target Trend
Apr 6, 2026 Oct 26, 2026
EPS Estimates
0q —
+1q —
0y —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days